Birmingham, West Midlands -- (SBWIRE) -- 10/18/2013 -- Value Penny Stocks issues special report on LG Display Co Ltd. (ADR) (NYSE:LPL), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Rockwell Medical Inc (NASDAQ:RMTI), Capstead Mortgage Corporation (NYSE:CMO).
LG Display Co Ltd. (ADR) (NYSE:LPL) opened its last trade at the price of $11.36. Its closing price was $11.81 after gaining 2.52% for the day. The company traded with the total volume of 1,143,161 shares, while its average trading volume remained 530,696.00 shares. The beta of this stock stands at 1.62. LG Display Co., Ltd. engages in the manufacture and sale of thin film transistor liquid crystal display (TFT-LCD) panels in the Republic of Korea, the United States, Europe, China, and rest of Asia. It offers TFT-LCD and other display panels comprising large-sized panels for use in televisions, notebook computers, and desktop monitors.
For How Long LPL will Fight for Profitability? Read This Trend Analysis report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) percentage change surged 2.64% to close at $12.05 with the total traded volume of 2,707,056 shares, along with average volume of 1.89 million shares. The 52 week range of the stock remained $4.80 - $12.38, while its day lowest price was $11.50. The share price hit the day highest price of $12.38. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
For How Long HALO’s Gloss will Attract Investors? Find out via this report
Rockwell Medical Inc (NASDAQ:RMTI) traded on volume of 2,146,614 shares in the last session against average volume of 3.86 million shares. The company started its trading session with the price of $11.54 and closed at $12.13 by scoring +4.21%. Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD).
Will RMTI Continue To Move Higher? Find Out Here
Capstead Mortgage Corporation (NYSE:CMO) started its last trading session with the price of $11.82 and closed at $12.15 by scoring +2.88%. The stock traded with total volume of 1,036,141 shares, while the average trading volume remained 1.50 million shares. The beta value of this stock stands at 0.46. Day range for the stock was $11.81 - $12.15. Capstead Mortgage Corporation operates as a real estate investment trust in the United States. It invests in a portfolio of residential mortgage pass-through securities consisting of adjustable-rate mortgage securities issued and guaranteed by government-sponsored enterprises or by an agency of the federal government.
Why Should Investors Buy CMO After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)